Department of Nephrology, Akron Children's Hospital, Akron, OH, USA.
Department of Nephrology, Cleveland Clinic Akron General/Akron Nephrology Associates, Akron, OH, USA.
Pediatr Res. 2022 Jan;91(1):44-55. doi: 10.1038/s41390-021-01452-3. Epub 2021 Mar 17.
The objective of this study was to inform the pediatric nephrologists of recent advances in acute kidney injury (AKI) epidemiology, pathophysiology, novel biomarkers, diagnostic tools, and management modalities. Studies were identified from PubMed, EMBASE, and Google Scholar for topics relevant to AKI. The bibliographies of relevant studies were also reviewed for potential articles. Pediatric (0-18 years) articles from 2000 to May 2020 in the English language were included. For epidemiological outcomes analysis, a meta-analysis on data regarding AKI incidence, mortality, and proportion of kidney replacement therapy was performed and an overall pooled estimate was calculated using the random-effects model. Other sections were created highlighting pathophysiology, novel biomarkers, changing definitions of AKI, evolving tools for AKI diagnosis, and various management modalities. AKI is a common condition seen in hospitalized children and the diagnosis and management have shown to be quite a challenge. However, new standardized definitions, advancements in diagnostic tools, and the development of novel management modalities have led to increased survival benefits in children with AKI. IMPACT: This review highlights the recent innovations in the field of AKI, especially in regard to epidemiology, pathophysiology, novel biomarkers, diagnostic tools, and management modalities.
本研究旨在向儿科肾脏病医师介绍急性肾损伤(AKI)的最新流行病学、病理生理学、新型生物标志物、诊断工具和治疗方法。通过 PubMed、EMBASE 和 Google Scholar 检索了与 AKI 相关的研究,还查阅了相关研究的参考文献,以寻找可能的文章。纳入了 2000 年至 2020 年 5 月期间发表的英文儿科(0-18 岁)文章。对于流行病学结局分析,对 AKI 发病率、死亡率和肾脏替代治疗比例的数据进行了荟萃分析,并使用随机效应模型计算了总体汇总估计值。其他部分则重点介绍了病理生理学、新型生物标志物、AKI 定义的变化、AKI 诊断工具的不断发展以及各种治疗方法。AKI 是住院儿童中常见的病症,其诊断和治疗极具挑战性。然而,新的标准化定义、诊断工具的进步以及新型治疗方法的发展,使得 AKI 患儿的生存率得到了提高。影响:本综述强调了 AKI 领域的最新创新,特别是在流行病学、病理生理学、新型生物标志物、诊断工具和治疗方法方面。